BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,724,053 | -12.4% | 213,434 | -22.0% | 0.14% | -13.7% |
| Q1 2023 | $11,097,784 | -32.1% | 273,614 | -14.7% | 0.16% | -25.8% |
| Q4 2022 | $16,345,111 | -5.0% | 320,681 | +0.4% | 0.22% | -12.1% |
| Q3 2022 | $17,211,000 | -41.5% | 319,548 | -30.2% | 0.25% | -40.6% |
| Q2 2022 | $29,406,000 | -22.6% | 457,819 | -6.5% | 0.42% | -5.7% |
| Q1 2022 | $37,985,000 | -1.6% | 489,880 | +8.9% | 0.44% | +10.8% |
| Q4 2021 | $38,615,000 | -48.0% | 449,849 | -51.3% | 0.40% | -47.2% |
| Q3 2021 | $74,255,000 | +2.4% | 923,223 | +2.5% | 0.75% | +6.5% |
| Q2 2021 | $72,500,000 | +81.1% | 900,623 | +89.8% | 0.71% | +67.0% |
| Q1 2021 | $40,030,000 | +5.1% | 474,623 | 0.0% | 0.42% | -2.8% |
| Q4 2020 | $38,084,000 | -0.2% | 474,623 | 0.0% | 0.44% | -17.3% |
| Q3 2020 | $38,169,000 | -29.1% | 474,623 | -24.1% | 0.53% | -30.8% |
| Q2 2020 | $53,855,000 | +12.1% | 625,495 | +5.7% | 0.76% | -18.2% |
| Q1 2020 | $48,058,000 | +6.5% | 591,921 | +9.7% | 0.93% | +30.3% |
| Q4 2019 | $45,128,000 | +45.1% | 539,675 | +51.8% | 0.72% | +23.7% |
| Q3 2019 | $31,102,000 | +20.9% | 355,568 | +13.2% | 0.58% | +31.7% |
| Q2 2019 | $25,736,000 | +8.0% | 314,237 | +7.2% | 0.44% | -66.5% |
| Q1 2019 | $23,838,000 | +42.3% | 293,174 | +15.2% | 1.31% | +19.1% |
| Q4 2018 | $16,754,000 | -17.5% | 254,543 | -3.3% | 1.10% | -14.4% |
| Q3 2018 | $20,301,000 | +30.9% | 263,348 | +25.4% | 1.29% | -2.6% |
| Q2 2018 | $15,506,000 | +10.4% | 210,000 | -2.8% | 1.32% | -5.0% |
| Q1 2018 | $14,049,000 | +0.6% | 216,000 | 0.0% | 1.39% | -4.6% |
| Q4 2017 | $13,962,000 | +3.0% | 216,000 | 0.0% | 1.46% | +2.9% |
| Q3 2017 | $13,554,000 | +8.7% | 216,000 | +4.9% | 1.42% | -3.9% |
| Q2 2017 | $12,471,000 | +26.6% | 206,000 | +8.4% | 1.48% | +12.3% |
| Q1 2017 | $9,853,000 | +16.9% | 190,000 | 0.0% | 1.31% | -23.9% |
| Q4 2016 | $8,425,000 | -6.8% | 190,000 | 0.0% | 1.72% | +5.6% |
| Q3 2016 | $9,044,000 | +20.5% | 190,000 | +14.5% | 1.63% | +15.6% |
| Q2 2016 | $7,507,000 | +40.6% | 166,000 | +27.7% | 1.41% | +45.8% |
| Q1 2016 | $5,340,000 | – | 130,000 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |